HEALTHglobal

Crossbow raises $77M for new cancer immunotherapies

Single source

Updated 2 hours ago

First seen March 18, 2026 17:11:22

Stay on top of this story

Follow the names and topics behind it.

Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.

Create a free account to sync your watchlist, saved stories, and alerts across devices.

Backed by more than a dozen investors, the biotech startup will use the funding to further a Phase 1 trial of its lead program CBX-250.